Announcement on Voluntary Disclosure of Acceptance of the New Drug Application for Marketing of the RET Inhibitor Sotolitinib Tablets (SY-5007)
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment